tiprankstipranks
INOVIQ Secures A$7M for Cancer Research Advancement
Company Announcements

INOVIQ Secures A$7M for Cancer Research Advancement

Inoviq Ltd (AU:IIQ) has released an update.

INOVIQ Ltd has successfully raised A$7 million through a placement at A$0.50 per share, with a plan for existing shareholders to further participate in a Share Purchase Plan (SPP) aiming to raise up to A$2.4 million. The funds will expedite the company’s development of cancer diagnostics and therapeutics, including the EXO-NET research tools and SubB2M diagnostics. The investment underscores confidence in INOVIQ’s proprietary technology and strategic multi-stage approach to growth in the biotech sector.

For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskINOVIQ Announces Shareholder Meeting Date
TipRanks Australian Auto-Generated NewsdeskInoviq Ltd Unveils Key Shareholders in Options Distribution
TipRanks Australian Auto-Generated NewsdeskInoviq Ltd Expands Offerings with New Options
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!